Abstract
Background
This study was to assess the influence of perioperative blood transfusions on the prognosis of patients undergoing a potentially curative resection for gastric cancer and to investigate the interaction between transfusions and splenectomy.
Materials and Methods
Between January 1990 and December 2005, 927 patients from 6 Italian tertiary referral centers underwent curative resections for gastric cancer. Clinical and pathologic variables were prospectively collected. The influence of perioperative blood transfusions on survival were evaluated by univariate and multivariate analysis. Moreover, the influence of splenectomy both in transfused and nontransfused patients undergoing total gastrectomy was also evaluated.
Results
The overall 5-year survival was 54.6%. The 5-year survival rate in transfused patients (n = 327) was 50.6% compared with 56.6% in nontransfused patients (n = 600) (P = .094). In the subgroup of patients who underwent total gastrectomy with spleen preservation (n = 209), 5-year survival rate was 46% and 51.4% in transfused and nontransfused patients, respectively (P = .418); those who underwent total gastrectomy with splenectomy (n = 199) presented a 5-year survival rate of 45% in transfused group compared with 39.1% in nontransfused patients (P = .571).
Conclusions
Our study indicates a slightly, but not significantly, negative effect of allogeneic blood transfusion on prognosis of gastric cancer patients. In the subgroup of patients who underwent total gastrectomy, splenectomy seems to invert this mild effect, with a positive influence on overall survival.
Similar content being viewed by others
References
Vamvakas EC, More SB. Blood transfusion and postoperative septic complications. Transfusion. 1994;34:714–27.
Blumberg N, Heal J, Chuang C, Murphy P, Agarwal M. Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg. 1988;207:410–5.
Maeta M, Shimizu N, Oka A, Kondo A, Yamashiro H, Tsujitani S, et al. Perioperative blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric carcinoma. J Surg Oncol. 1994;55:149–53.
Bellantone R, Sitges-Serra A, Bossola M, Doglietto GB, Malerba M, Franch G, et al. Transfusion timing and postoperative septic complications after gastric cancer surgery. A retrospective study of 179 consecutive patients. Arch Surg. 1998;133:988–92.
Yamashita K, Sakuramoto S, Kikuchi S, Katada N, Kobayashi N, Watanabe M. Transfusion alert for patients with curable cancer. World J Surg. 2007;31:2315–22.
Hyung WJ, Noh SH, Shin DW, Huh J, Huh BJ, Choi SH, et al. Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol. 2002;9:5–12.
Marquet RL, Heineman E, Tank B, Obertop H, Niessen GJ, Bijnen AB, et al. Abrogation of the beneficial blood transfusion effect in dogs by splenectomy. World J Surg. 1984;8:408–13.
Shelby J, Wakely E, Corry RJ. Suppressor cell induction in donor specific transfused mouse heart recipients. Surgery. 1984;96:296–301.
Shelby J, Wakley E, Corry RJ. Splenectomy abrogates the improved graft survival achieved by donor-specific transfusion. Transplant Proc. 1985;17:1083–6.
Monig SP, Collet PH, Baldus SE, Schmackpfeffer K, Schröder W, Thiele J, et al. Splenectomy in proximal gastric cancer: Frequency of lymph node metastasis to the splenic hilus. J Surg Oncol. 2001;76:89–92.
Kitamura K, Nishida S, Yamamoto K, Ichikawa D, Okamoto K, Taniguchi H, et al. Lymph node metastasis in gastric cancer in the upper third of the stomach: Surgical treatment on the basis of the anatomical distribution of positive node. Hepatogastroenterology. 1998;45:281–5.
Sakaguchi T, Sawada H, Yamada Y, Fujimoto H, Emoto K, Takayama T, et al.: Indication for splenectomy for gastric carcinoma involving the proximal part of the stomach. Hepatogastroenterology. 2001;48:603–5.
Nishi M, Omori Y, Miwa K. Japanese Research Society for Gastric Cancer (JRSGC). Japanese classification of gastric carcinoma. 1st English ed. Tokyo: Kanehara; 1995. p. 6–15.
Greene FL, Page DL, Fleming ID, Fritz AG, Balch MC, Haller DG, et al. AJCC cancer staging manual. 6th ed. Chicago: Springer; 2002.
Sugezawa A, Kaibara N, Sumi K, Ohta M, Kimura O, Nishidoi H, et al. Blood transfusion and the prognosis of patients with gastric cancer. J Surg Oncol. 1989;42:113–6.
Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg. 1994;167:256–60.
Kampschoer GH, Maruyama K, Sasako M, Kinoshita T, van de Velde CJ. The effects of blood transfusion on the prognosis of patients with gastric cancer. World J Surg. 1989;13:637–43.
Kaneda M, Horimi T, Ninomiya M, Nagae S, Mukai K, Takeda I, et al. Adverse affect of blood transfusions on survival of patients with gastric cancer. Transfusion. 1987;27:375–7.
Sánchez-Bueno F, Garcia-Marcilla JA, Pérez-Abad JM, Vicente R, Aranda F, Lujan JA, et al. Does perioperative blood transfusion influence long-term prognosis of gastric cancer? Dig Dis Sci. 1997;42:2072–6.
Moriguchi S, Maehara Y, Akazawa K, Sugimachi K, Nose Y. Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer. Cancer. 1990;66:2331–5.
Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, et al. Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg. 2009;13:1821–30.
Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion. 1990;30:651–8.
Sy MS, Miller SD, Kowach HB, Claman HN. A splenic requirement for the generation of suppressor T cells. J Immunol. 1977;119:2095–9.
Heiss MM, Allgayer H, Gruetzner KU, Tarabichi A, Babic R, Mempel W, et al. Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients. Anticancer Res. 1997;17:2657–61.
Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, Maluenda F. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery. 2002;131:401–7.
Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Br J Cancer. 1999;79:1522–30.
Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908–14.
Llende M, Santiago-Delpin EA, Lavergne J. Immunobiological consequences of splenectomy: a review. J Surg Res. 1986;40:85–94.
Griffith JP, Sue-Ling HM, Dixon MI, Dixon MF, McMahon MJ, Axon AT, et al. Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut. 1995;36:684–90.
Wanebo HJ, Kennedy BJ, Winchester DP, Stewart AK, Fremgen AM. Role of splenectomy in gastric cancer surgery: Adverse effect of elective splenectomy on long-term survival. J Am Coll Surg. 1997;185:177–84.
Brady MS, Rogatko A, Dent L, Shiu MH. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg. 1991;126:359–64.
Martin RC, Jaques DP, Brennan MF, Jaques DP. Extended local resection for advanced gastric cancer: Increased survival versus increased morbidity. Ann Surg. 2002;236:159–65.
Yamaguchi Y, Goto M, Makino Y, Kikuchi N, Hamaguchi H, Hisama N, et al. Prolonged survival of rat hepatic allografts pretreated with single donor-specific blood transfusion: The distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient. J Surg Res. 1996;61:23–9.
Weitz J, D’Angelica M, Gonen M, Klimstra D, Coit DG, Brennan MF, et al. Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. J Clin Oncol. 2003;21:4597–603.
Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH. Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion. Am J Surg. 2006;193:301–5.
Acknowledgment
Prof. Fabio Pacelli had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study is conducted on behalf of the Italian Research Group for Gastric Cancer—IRGGC.
Rights and permissions
About this article
Cite this article
Pacelli, F., Rosa, F., Marrelli, D. et al. Do Perioperative Blood Transfusions Influence Prognosis of Gastric Cancer Patients? Analysis of 927 Patients and Interactions with Splenectomy. Ann Surg Oncol 18, 1615–1623 (2011). https://doi.org/10.1245/s10434-010-1543-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-010-1543-9